Skip to main content

Table 4 Prevalences of protective antibodies to measles, mumps, and rubella after vaccination in HIV-infected adults and HIV-uninfected controls

From: Seroprevalence of antibodies to measles, mumps, and rubella, and serologic responses after vaccination among human immunodeficiency virus (HIV)-1 infected adults in Northern Thailand

 

HIV-infected adults

HIV-uninfected controls

 

Baseline

Week 8–12

Week 48

Baseline

Week 8–12

Week 48

Measles

Presence of protective antibody to measles

All

222/249 (89.2)

240/249 (96.4)

234/247 (94.7)

44/46 (95.7)

46/46 (100)

44/46 (95.7)

Detectable baseline protective antibody to measles

-

220/222 (99.1)

219/220 (99.6)

-

44/44 (100)

43/44 (97.7)

No baseline protective antibody to measles

-

20/27 (74.1)

15/27 (55.6)

-

2/2 (100)

1/2 (50)

Anti-measles IgG level (mIU/mL)

All

2654 (1132, 4768)

2771 (1315, 4911)

2604 (1208, 5061)

3353.5 (2035, 5834)

3221.5 (1367, 5232)

2863.5 (1659, 5164)

Detectable baseline protective antibody to measles

2946 (1560, 5082)

3022.5 (1674, 5225)

2993 (1572.5, 5291)

3450.5 (2215, 5970.5)

3254.5 (1427.5, 5313.5)

2977 (1720.5, 5508.5)

No baseline protective antibody to measles

200 (148, 269)

616 (289, 2049)

394 (228, 961)

137 (129, 145)

1791.5 (342, 3241)

965.5 (226, 1705)

Mumps

Presence of protective antibody to mumps

All

42/249 (16.9)*

176/249 (70.7)**

182/247 (73.7)***

16/46 (34.8)*

40/46 (87.0)**

40/46 (87.0)***

Detectable baseline protective antibody to mumps

-

40/42 (95.2)

42/42 (100)

-

13/16 (81.3)

14/16 (87.5)

No baseline protective antibody to mumps

-

136/207 (65.7)****

140/205 (68.3)*****

-

27/30 (90)****

26/30 (86.7)*****

Anti-mumps IgG titer (1:xxxx)

All

220 (61, 431)

1086 (423, 2818)

886 (457, 1820)

247 (107, 399)

1821 (1223, 3375)

1191.5 (696, 1997)

Detectable baseline protective antibody to mumps

1221 (785, 2765)

2550 (1198, 4523)

1836.5 (1089, 3443)

474 (148, 890)

2280 (1278, 4006)

1653 (804, 2054.5)

No baseline protective antibody to mumps

151 (36, 323)

923 (337, 2227)

777 (361, 1391)

200 (101, 328)

1695 (1223, 2819)

1094.5 (629, 1997)

Rubella

Presence of protective antibody to rubella

All

174/249 (69.9)

244/249 (98.0)

241/247 (97.6)

35/46 (76.1)

46/46 (100)

46/46 (100)

Detectable baseline protective antibody to rubella

-

174/174 (100)

171/172 (99.4)

-

35/35 (100)

35/35 (100)

No baseline protective antibody to rubella

-

70/75 (93.3)

70/75 (93.3)

-

11/11 (100)

11/11 (100)

Anti-rubella IgG level (IU/mL)

All

27 (5, 74)

51 (27, 90)

47 (22, 87)

15 (7, 40)

47.5 (26, 86)

37 (21, 61)

Detectable baseline protective antibody to rubella

47.5 (23, 99)

57.5 (27, 103)

42.5 (22, 91.5)

35 (21, 55)

47 (26, 86)

35 (21, 55)

No baseline protective antibody to rubella

1 (1, 1)

45 (25, 68)

52 (23, 79)

1 (1, 7)

51 (11, 95)

42 (10, 42)

  1. * p-value = 0.005, ** p-value = 0.022, *** p-value = 0.061, **** p-value = 0.007, ***** p-value = 0.039